Serological survey of nasopharyngeal carcinoma in 21 cities of south China. 1995

H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
Wuzhou Institute for Cancer Research, Guangxi.

This paper reports the results of serological survey of 318,912 persons for nasopharyngeal carcinoma (NPC) in 21 cities and counties of south China. There were 8,441 persons with positive VCA-IgA antibody (single item positive) of EB virus (EBV), with a rate of 2.65%. In these VCA-IgA positive persons, 287 persons also had positive EA-IgA (double items positive) of EBV. The overall positive rate was 0.09%. 100 cases of NPC were found and 87 of them (87.0%) were in early stage. NPC found in the group with single item positive accounts for 1.19%, but the rate in the group with double items positive was 19.16% (55 cases). In NPC patients with double items positive, 49 cases were in early stage (89.1%). In 100 cases of NPC found, 45 cases appeared with negative EA-IgA, only with positive VCA-IgA, which indicated that for diagnosis of NPC, sensitivity of EA-IgA was lower than that of VCA-IgA, but its specificity was higher. Therefore, both can increase the detecting rate and early diagnosis rate of NPC. The age of people checked varied with different antibody positive rate and NPC detecting rate. The three items showed a positive correlation. The results are compatible with those of the prospective study for NPC in Wuzhou City, Guangxi, China. The method for NPC serological diagnosis can be extended and applied to raise the NPC detecting rate and early diagnosis rate at secondary prevention. And, it is further proved that there is a close relationship between NPC and EBV.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
February 1982, International journal of cancer,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
December 1979, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
August 2019, Cancer medicine,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
November 1995, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
January 2019, Frontiers in oncology,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
April 1982, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
February 2009, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
February 1990, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
January 2020, Cancer communications (London, England),
H Deng, and Y Zeng, and Y Lei, and Z Zhao, and P Wang, and B Li, and Z Pi, and B Tan, and Y Zheng, and W Pan
March 2011, Chinese journal of cancer,
Copied contents to your clipboard!